Sunho Biologics Inc. Files List of Directors With HKEX

Reuters
Mar 03
Sunho Biologics Inc. Files List of Directors With HKEX

Sunho Biologics Inc. (HKEX: 2898) filed an updated list of directors effective Feb. 28, 2026. Executive directors are Zhang Feng and Jiang Xiaoling, and Fan Rongkui serves as a non-executive director. Independent non-executive directors are Chan Heung Wing Anthony, Feng Lan and Shi Luwen. Committee memberships are as follows: Chan Heung Wing Anthony is chairman of the Audit Committee, with Feng Lan and Shi Luwen as members. Feng Lan is chair of the Remuneration Committee, with Zhang Feng and Shi Luwen as members. Zhang Feng is chairman of the Nomination Committee, with Feng Lan and Shi Luwen as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunho Biologics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260303-12038910), on March 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10